Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs12549917 | chr8:116877150 | A/G | 8.4E-7 | 133 | 45.1 | 31.78 | 18.83 | KM Plot |
| TGCT | rs12578725 | chr12:129566270 | G/T | 1.01E-13 | 134 | 17.1 | 46.53 | 40.57 | KM Plot |
| TGCT | rs12586299 | chr14:71085215 | C/T | 1.68E-5 | 131 | 40.57 | 56.83 | 21.43 | KM Plot |
| TGCT | rs12587714 | chr14:71004376 | G/C | 1.3E-5 | 134 | 38.2 | 66.9 | 21.43 | KM Plot |
| TGCT | rs12599370 | chr16:27810989 | G/A | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs12599373 | chr16:27811044 | G/C | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs12599374 | chr16:27811045 | G/A | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs12599387 | chr16:27811102 | G/A | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs12625235 | chr20:57201798 | G/A | 2.68E-9 | 129 | 37.1 | 60.68 | 9.02 | KM Plot |
| TGCT | rs12640171 | chr4:58374190 | A/T | 0 | 131 | 42.1 | 53.83 | 0.5 | KM Plot |
| TGCT | rs12643003 | chr4:58374247 | G/T | 0 | 131 | 42.1 | 53.83 | 0.5 | KM Plot |
| TGCT | rs12676086 | chr8:116909222 | C/A | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs12775195 | chr10:27578679 | C/A | 2.11E-12 | 129 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs12775838 | chr10:27573707 | G/T | 1.64E-12 | 130 | 42.18 | 45.83 | 20.6 | KM Plot |
| TGCT | rs12777898 | chr10:27583147 | G/A | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |